DEF: Select Medical Holdings Corporation Announces 2025 Annual Meeting of Stockholders, Proposes Amendment to Eliminate Supermajority Voting

Select Medical Holdings Corporation will hold its 2025 Annual Meeting of Stockholders virtually on April 24, 2025, to vote on director elections, an amendment to eliminate supermajority voting, director compensation policy, and other proposals.

Summary

• Select Medical Holdings Corporation is holding its 2025 Annual Meeting of Stockholders virtually on April 24, 2025.
• Stockholders of record as of February 28, 2025, are eligible to vote.
• The meeting agenda includes the election of four Class I directors, approval of an amendment to eliminate supermajority voting requirements, approval of the non-employee director compensation policy, a vote on a stockholder proposal to elect each director annually, an advisory vote on executive compensation, and ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors recommends voting FOR the director nominees, FOR the amendment to eliminate supermajority voting, FOR the non-employee director compensation policy, NO RECOMMENDATION on the stockholder proposal to elect each director annually, FOR the executive compensation resolution, and FOR the ratification of PricewaterhouseCoopers LLP.
• The company's Board consists of 10 directors, 8 of whom are considered independent.
• In 2024, the Compensation Committee determined that NEO bonuses would be based on the company's achievement of specified levels of earnings per share and return on equity.
• For 2024, the Compensation Committee established target and maximum earnings per share levels of $1.88 and $2.07, respectively, and established target and maximum return on equity levels of 16.40% and 17.22%, respectively.
• The company achieved adjusted earnings per share of $2.28 and a return on equity of 19.1%, resulting in bonuses equaling 250% of target for each NEO participant.
• The company's non-employee directors will receive annual restricted stock awards equal to $200,000.
• The company paid approximately $7.6 million in office rent to Ortenzio Partnerships in fiscal year 2024.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, outlining the agenda and proposals for the annual meeting. The positive financial performance (EPS and ROE) contributes to a slightly positive sentiment.

Positives

• The company is proposing to eliminate supermajority voting requirements, which could promote stockholder participation and facilitate faster decision-making.
• The company achieved adjusted earnings per share of $2.28 and a return on equity of 19.1%, resulting in bonuses equaling 250% of target for each NEO participant.
• The company's non-employee directors will receive annual restricted stock awards equal to $200,000.

Negatives

• The company paid approximately $7.6 million in office rent to Ortenzio Partnerships in fiscal year 2024.

Risks

• The company faces a number of risks, including regulatory risk, credit risk, liquidity risk, reputational risk, risk from adverse fluctuations in interest rates and cybersecurity risk.
• The company's financial performance is heavily dependent upon the constantly changing and complex regulatory environment in which the company operates, including changes in Medicare payment rates and formulae.

Future Outlook

The Board of Directors will reexamine its position with respect to the classified board structure and anticipates it would seek additional feedback from investors as part of this evaluation.

Management Comments

• The Board of Directors believes that the Director Compensation Policy is fair and in the best interests of all stockholders of the Company and closely aligns the interests of the non-employee directors with stockholders.
• The Board of Directors encourages the Company's stockholders to approve the Executive Compensation Resolution.

Industry Context

The document reflects standard corporate governance practices, including proxy solicitations, director elections, and executive compensation disclosures, common among publicly traded companies.

Comparison to Industry Standards

• The company's executive compensation program is designed to reward the NEOs contributions to the company's financial performance and provide overall compensation sufficient to attract and retain highly skilled NEOs who are properly motivated to contribute to the company's financial performance.
• The company's non-employee director compensation policy is designed to attract, retain, and motivate non-employee directors to contribute to the success of the company.
• The company's cybersecurity program is structured around the cybersecurity framework (Cybersecurity Framework) of the National Institute of Standards and Technology (NIST), an agency of the U.S. Department of Commerce.

Corporate Governance

Related Party Transactions

• The Company leases office space from Ortenzio Partnerships, paying approximately $7.6 million in fiscal year 2024.
• Select entered into a letter agreement with Robert Ortenzio allowing Select to use the aircraft leased by Robert Ortenzio through an arrangement with NetJets Aviation Inc., NetJets Sales, Inc. and NetJets Services, Inc.

Stakeholder Impact

• Stockholders will have the opportunity to vote on key governance matters, including director elections and the elimination of supermajority voting requirements.
• Executive officers' compensation is tied to the company's financial performance, aligning their interests with those of stockholders.
• The company's cybersecurity program aims to protect the data of customers, patients, and employees.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The Board of Directors will consider the outcome of the advisory vote on executive compensation when evaluating the company's compensation programs and practices.
• If the stockholder proposal is approved, the Company would propose this amendment at the 2026 Annual Meeting.

Key Dates